MemoHoney Official Website › Side Effects
Side EffectsMemoHoney side effects and the one interaction worth naming
The interaction that matters is with blood pressure medicine.
Four of the six named ingredients relax blood vessels, which is the same thing a blood pressure drug, a nitrate or a drug for erectile dysfunction does. Beyond that, the known effects of these ingredients at studied doses are mild and mostly digestive, plus a tingling that beta-alanine produces at large single doses.
This page names specific interactions rather than repeating a general caution. A general caution is what people skip.
The MemoHoney interaction that deserves a conversation
L-arginine, arginine AKG and both citrulline forms all feed the same pathway: more nitric oxide, relaxed vessels, lower blood pressure. the 2026 arginine blood pressure meta-analysis measured 24-hour systolic falling about 4.2 mmHg on oral arginine across five trials, and the citrulline blood pressure review found citrulline lowering pressure in middle-aged and older adults.
A 4 mmHg fall is helpful in someone untreated and unhelpful in someone whose pressure is already being managed downward by a drug. The same applies with greater force to nitrates, which act directly on the same pathway, and to drugs for erectile dysfunction, which prolong its downstream signal.
So the instruction is specific: if you take a blood pressure medicine, a nitrate of any kind, or a PDE5 inhibitor, tell your prescriber you are starting a capsule containing arginine and citrulline. That is a one-sentence conversation and it is worth having before the first capsule.
the VINTAGE MI trial gave 9 grams of L-arginine a day for six months to people recovering from a heart attack. It was stopped early: vascular stiffness did not improve and more deaths occurred in the arginine group, and the authors concluded arginine should not be recommended after a myocardial infarction. That is a specific population at a dose far above anything a capsule carries, and it is why nobody should treat an amino acid as automatically inert.
What each MemoHoney ingredient is known to do at studied doses
| Ingredient | Reported at trial doses | What that dose was |
|---|---|---|
| L-Arginine | Digestive upset, loose stools, lower blood pressure | 6 to 9 g a day |
| L-Arginine AKG 2:1 | Digestive upset at the larger doses | 3 g acute, 10 to 12 g daily |
| L-Citrulline HCL | Well tolerated; less digestive upset than arginine | 3 g twice a day |
| L-Citrulline Malate | Stomach discomfort at the higher acute doses | 6 to 12 g acute |
| Niacin (B3) | Flushing, itching, liver and muscle signals at drug doses | Dietary intake; 2 g a day in the lipid trials |
| Beta-Alanine | Paraesthesia, the tingling that follows a large single dose | 4 to 6.4 g a day, divided |
Every effect listed comes from a trial at the dose in the third column. This capsule carries no amount, so none of these can be predicted for it one way or the other.
Two rows need context. The niacin row lists effects reported at 2 grams a day of extended-release niacin in the HPS2-THRIVE safety report, a cardiovascular trial in 25,673 people. That is a drug dose. No memory capsule carries it, and quoting it without saying so would be alarmist.
The beta-alanine row describes paraesthesia, which the ISSN position stand on beta-alanine identifies as the only commonly reported side effect and links to single doses above roughly 800 mg. It is harmless and it is startling the first time. the beta-alanine risk assessment, the systematic risk assessment, found no evidence of harm within the doses used in the published research.
Who should not take MemoHoney at all
- Anyone under 18.
- Anyone pregnant or nursing. None of the six has safety data at supplemental doses in pregnancy, and the label carries no amount to assess.
- Anyone on a nitrate. This is the sharpest of the vascular interactions.
- Anyone with a history of herpes simplex outbreaks who has been told to limit arginine, which is a long-standing clinical caution worth raising with whoever gave it.
- Anyone recovering from a recent heart attack, on the strength of the trial cited above.
- Anyone whose memory has changed in a way they or those around them have noticed. That needs assessing, and a capsule postpones it.
a 2026 pellagra case report is a useful reminder of why the last line matters. It describes cognitive impairment from a vitamin deficiency that reversed once it was identified. Thyroid disease, B12 deficiency, sleep apnoea, depression, hearing loss and several common medicines all produce memory complaints, and all of them are addressable by somebody who looks.
What to do if MemoHoney disagrees with you
Stop taking it
One capsule a day means there is nothing to taper. Stopping is simply stopping.
Write down what happened and when
What you felt, which day of the bottle, what else changed that week. It is the only record anyone will have.
Speak to a clinician if anything is more than mild
Take the bottle with you. The six names on it are the information they will want, and there are no amounts to give them.
Call the order desk about the money
+1 (302) 200-3480 with the order ID. The 60-day window covers opened bottles, which is the whole point of it.
Sources behind this MemoHoney safety page
- Shi Y, Liu Y, Zhou Z, et al. Reassessment of the effect of oral l-arginine on blood pressure: A systematic review and meta-analysis based on ambulatory blood pressure monitoring. Nitric Oxide. 2026;164:60-68. PMID 42520885. https://pubmed.ncbi.nlm.nih.gov/42520885/
- Schulman SP, Becker LC, Kass DA, et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295(1):58-64. PMID 16391217. https://pubmed.ncbi.nlm.nih.gov/16391217/
- Luo P, Chen J, Liu K, et al. Does l-citrulline supplementation and watermelon intake reduce blood pressure in middle-aged and older adults? A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2025;69:653-664. PMID 40789388. https://pubmed.ncbi.nlm.nih.gov/40789388/
- HPS2-THRIVE Collaborative Group. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur Heart J. 2013;34(17):1279-91. PMID 23444397. https://pubmed.ncbi.nlm.nih.gov/23444397/
- Ferrell M, Wang Z, Anderson JT, et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nat Med. 2024;30(2):424-434. PMID 38374343. https://pubmed.ncbi.nlm.nih.gov/38374343/
- Ramos D, Valente A, Leão R, et al. Marchiafava-Bignami Disease and Pellagra in a Chronic Alcohol User: A Reversible Case of Cognitive Impairment. Cureus. 2026;18(1):e102149. PMID 41732620. https://pubmed.ncbi.nlm.nih.gov/41732620/
- Trexler ET, Smith-Ryan AE, Stout JR, et al. International society of sports nutrition position stand: Beta-Alanine. J Int Soc Sports Nutr. 2015;12:30. PMID 26175657. https://pubmed.ncbi.nlm.nih.gov/26175657/
- Dolan E, Swinton PA, Painelli VS, et al. A Systematic Risk Assessment and Meta-Analysis on the Use of Oral β-Alanine Supplementation. Adv Nutr. 2019;10(3):452-463. PMID 30980076. https://pubmed.ncbi.nlm.nih.gov/30980076/
Order MemoHoney once the medicine question is settled
One conversation with a prescriber if you take anything that works on blood vessels, and then a capsule a day. The window covers the rest.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order MemoHoney On The Official WebsiteOne capsule a day · 30 per bottle · lot MEM-26/ME-1451
